Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 4.052% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: Cc1cccc(NC(=O)CCOc2ccccc2)c1
b: CN(C)CCC#CC1(O)c2ccccc2-c2ccccc21
c: Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc4nc[nH]c4c3)CC2)cc1
d: Cc1ccc(-c2ccc(SCC(=O)Nc3nonc3C)nn2)cc1
Answer: d. Cc1ccc(-c2ccc(SCC(=O)Nc3nonc3C)nn2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2ccc(SCC(=O)Nc3nonc3C)nn2)cc1
Cc1ccc(-c2ccc(SCC(=O)Nc3nonc3C)nn2)cc1
N-(4-methyl-1,2,5-oxadiazol-3-yl)-2-[6-(4-methylphenyl)pyridazin-3-yl]sulfanylacetamide